FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2038433223> ?p ?o ?g. }

• W2038433223 endingPage "269" @default.
• W2038433223 startingPage "261" @default.
• W2038433223 abstract "Two new influenza virus neuraminidase inhibitors (NAIs), peramivir and laninamivir, were approved in 2010 which resulted to four NAIs that were used during the 2010-2011 influenza season in Japan. This study aims to monitor the susceptibility of influenza virus isolates in 2009-2010 and 2010-2011 influenza seasons in Japan to the four NAIs using the fluorescence-based 50% inhibitory concentration (IC₅₀) method. Outliers were identified using box-and-whisker plot analysis and full NA gene sequencing was performed to determine the mutations that are associated with reduction of susceptibility to NAIs. A total of 117 influenza A(H1N1)pdm09, 59 A(H3N2), and 18 type B viruses were tested before NAI treatment and eight A(H1N1)pdm09 and 1 type B viruses were examined from patients after NAI treatment in the two seasons. NA inhibition assay showed type A influenza viruses were more susceptible to NAIs than type B viruses. The peramivir and laninamivir IC₅₀ values of both type A and B viruses were significantly lower than the oseltamivir and zanamivir IC₅₀ values. Among influenza A(H1N1)pdm09 viruses, the prevalence of H274Y viruses increased from 0% in the 2009-2010 season to 3% in the 2010-2011 season. These H274Y viruses were resistant to oseltamivir and peramivir with 200-300 fold increase in IC₅₀ values but remained sensitive to zanamivir and laninamivir. Other mutations in NA, such as I222T and M241I were identified among the outliers. Among influenza A(H3N2) viruses, two outliers were identified with D151G and T148I mutations, which exhibited a reduction in susceptibility to oseltamivir and zanamivir, respectively. Among type B viruses, no outliers were identified to the four NAIs. For paired samples that were collected before and after drug treatment, three (3/11; 27.3%) H274Y viruses were identified among A(H1N1)pdm09 viruses after oseltamivir treatment but no outliers were found in the laninamivir-treatment group (n=3). Despite widespread use of NAIs in Japan, the prevalence of NAI-resistant influenza viruses is still low." @default.
• W2038433223 created "2016-06-24" @default.
• W2038433223 creator A5006257544 @default.
• W2038433223 creator A5012245547 @default.
• W2038433223 creator A5029461691 @default.
• W2038433223 creator A5040408001 @default.
• W2038433223 creator A5050976958 @default.
• W2038433223 creator A5061419722 @default.
• W2038433223 creator A5086987725 @default.
• W2038433223 creator A5088790062 @default.
• W2038433223 creator A5091853924 @default.
• W2038433223 date "2013-09-01" @default.
• W2038433223 modified "2023-09-26" @default.
• W2038433223 title "Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009–2010 and 2010–2011 influenza seasons in Japan" @default.
• W2038433223 cites W1833004935 @default.
• W2038433223 cites W1964422669 @default.
• W2038433223 cites W1965226808 @default.
• W2038433223 cites W1974728866 @default.
• W2038433223 cites W1975608032 @default.
• W2038433223 cites W1976576877 @default.
• W2038433223 cites W1977802495 @default.
• W2038433223 cites W1981438128 @default.
• W2038433223 cites W1984258526 @default.
• W2038433223 cites W2006977512 @default.
• W2038433223 cites W2015396574 @default.
• W2038433223 cites W2020852349 @default.
• W2038433223 cites W2030678438 @default.
• W2038433223 cites W2032390526 @default.
• W2038433223 cites W2033013922 @default.
• W2038433223 cites W2042995083 @default.
• W2038433223 cites W2057595548 @default.
• W2038433223 cites W2063205025 @default.
• W2038433223 cites W2063295841 @default.
• W2038433223 cites W2065419649 @default.
• W2038433223 cites W2067072957 @default.
• W2038433223 cites W2071591576 @default.
• W2038433223 cites W2085738229 @default.
• W2038433223 cites W2094103854 @default.
• W2038433223 cites W2096786557 @default.
• W2038433223 cites W2097230806 @default.
• W2038433223 cites W2104397822 @default.
• W2038433223 cites W2110116676 @default.
• W2038433223 cites W2111155300 @default.
• W2038433223 cites W2114005089 @default.
• W2038433223 cites W2119394949 @default.
• W2038433223 cites W2122548455 @default.
• W2038433223 cites W2125461332 @default.
• W2038433223 cites W2128060816 @default.
• W2038433223 cites W2130479394 @default.
• W2038433223 cites W2133708140 @default.
• W2038433223 cites W2155229144 @default.
• W2038433223 cites W2156231263 @default.
• W2038433223 cites W2161100389 @default.
• W2038433223 cites W2161420151 @default.
• W2038433223 cites W2164447052 @default.
• W2038433223 cites W2321663980 @default.
• W2038433223 cites W2409649694 @default.
• W2038433223 cites W2412996610 @default.
• W2038433223 doi "https://doi.org/10.1016/j.antiviral.2013.06.003" @default.
• W2038433223 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23791870" @default.
• W2038433223 hasPublicationYear "2013" @default.
• W2038433223 type Work @default.
• W2038433223 sameAs 2038433223 @default.
• W2038433223 citedByCount "42" @default.
• W2038433223 countsByYear W20384332232013 @default.
• W2038433223 countsByYear W20384332232014 @default.
• W2038433223 countsByYear W20384332232015 @default.
• W2038433223 countsByYear W20384332232016 @default.
• W2038433223 countsByYear W20384332232017 @default.
• W2038433223 countsByYear W20384332232018 @default.
• W2038433223 countsByYear W20384332232019 @default.
• W2038433223 countsByYear W20384332232020 @default.
• W2038433223 countsByYear W20384332232021 @default.
• W2038433223 countsByYear W20384332232022 @default.
• W2038433223 countsByYear W20384332232023 @default.
• W2038433223 crossrefType "journal-article" @default.
• W2038433223 hasAuthorship W2038433223A5006257544 @default.
• W2038433223 hasAuthorship W2038433223A5012245547 @default.
• W2038433223 hasAuthorship W2038433223A5029461691 @default.
• W2038433223 hasAuthorship W2038433223A5040408001 @default.
• W2038433223 hasAuthorship W2038433223A5050976958 @default.
• W2038433223 hasAuthorship W2038433223A5061419722 @default.
• W2038433223 hasAuthorship W2038433223A5086987725 @default.
• W2038433223 hasAuthorship W2038433223A5088790062 @default.
• W2038433223 hasAuthorship W2038433223A5091853924 @default.
• W2038433223 hasConcept C126322002 @default.
• W2038433223 hasConcept C134164806 @default.
• W2038433223 hasConcept C159047783 @default.
• W2038433223 hasConcept C2522874641 @default.
• W2038433223 hasConcept C2777538117 @default.
• W2038433223 hasConcept C2777546802 @default.
• W2038433223 hasConcept C2779134260 @default.
• W2038433223 hasConcept C2780374985 @default.
• W2038433223 hasConcept C2780689484 @default.
• W2038433223 hasConcept C2781442963 @default.
• W2038433223 hasConcept C2911097425 @default.
• W2038433223 hasConcept C3008058167 @default.
• W2038433223 hasConcept C524204448 @default.

• next